These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 25134972)

  • 21. Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study.
    Dogan A; Ergene O; Nazli C; Kinay O; Altinbas A; Ucarci Y; Ergene U; Ozaydin M; Gedikli O
    Acta Cardiol; 2004 Jun; 59(3):255-61. PubMed ID: 15255456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
    Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A
    Card Electrophysiol Rev; 2003 Jun; 7(2):178-84. PubMed ID: 14618047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.
    Opolski G; Stanisławska J; Górecki A; Swiecicka G; Torbicki A; Kraska T
    Clin Cardiol; 1997 Apr; 20(4):337-40. PubMed ID: 9098591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Piccini JP; Hasselblad V; Peterson ED; Washam JB; Califf RM; Kong DF
    J Am Coll Cardiol; 2009 Sep; 54(12):1089-95. PubMed ID: 19744618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation.
    Zapolski T; Wysokiński A
    Kardiol Pol; 2005 Sep; 63(3):254-62; discussion 263-4. PubMed ID: 16180181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the cost-effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia.
    Tesic D; Kostic M; Paunovic D; Jankovic SM
    Kardiol Pol; 2015; 73(4):287-95. PubMed ID: 25428811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of amiodarone for preventing the recurrence of symptomatic paroxysmal and persistent atrial fibrillation after cardioversion.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Nakamura M; Okumura K
    Circ J; 2007 Jan; 71(1):46-51. PubMed ID: 17186977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.
    Stroobandt R; Stiels B; Hoebrechts R
    Am J Cardiol; 1997 Feb; 79(4):418-23. PubMed ID: 9052343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses.
    Kochiadakis GE; Igoumenidis NE; Hamilos MI; Tzerakis PG; Klapsinos NC; Zacharis EA; Vardas PE
    Chest; 2004 Feb; 125(2):377-83. PubMed ID: 14769712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
    Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL
    Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
    Kosior D; Szulc M; Zawadzka M; Pierścińska M; Stawicki S; Rabczenko D; Torbicki A; Opolski G
    Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dronedarone.
    Tamargo J; López-Farré A; Caballero R; Delpón E
    Drugs Today (Barc); 2011 Feb; 47(2):109-33. PubMed ID: 21431100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the efficacy and safety of dronedarone and flecainide as maintenance antiarrhythmic therapy for sinus rhythm in atrial fibrillation].
    Sánchez Soriano RM; Chamorro Fernández CI; Ruiz Nodar JM; Chamorro Fernández AJ; Grau Jornet G; Nuñez Villota J
    Arch Cardiol Mex; 2018; 88(3):204-211. PubMed ID: 28864237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
    Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
    Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
    Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L;
    Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs].
    Viñolas X; Freire F; Romero-Menor C; Alegret JM
    Med Clin (Barc); 2013 Apr; 140(8):351-5. PubMed ID: 22982132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.